Abstract: Poly( -hydroxy acids), especially poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and their copolymers poly(lactic-co-glycolic acid) (PLGA) are novel class of commodity polymers, also used in biomedical applications. They can be synthesized with a controlled biodegradation rate and are biocompatible, bioresorbable and approved by US Food and Drug Administration (US FDA) for clinical use. Lactic acid polymers are developed in medicine (sutures, implants, orthopaedics, tissue engineering), pharmacy (controlled drug delivery systems) as well as in packaging, agriculture (mulch films, seed preservation), food applications, etc. The paper reviews recent literature data concerning lactic acid polymers synthesis (polycondensation, ring opening polymerization), physical (thermophysical, solubility, miscibility), mechanical properties, degradation behaviour, emphasizing on the poly( -hydroxyacids) and lactic acid polymers applications in medicine and pharmacy.
Introduction
The development of new biomaterials for medical applications is one of the challenging tasks for material science today. There is an obvious need for better implants as well as for the manufacturing of artificial tissues.
Poly(α-hydroxyacids) are an interesting class of biodegradable, biocompatible, bioresorbable polymers that decompose into physiologically tolerable, non-toxic degradation products that are eliminated from the organism or completely bioabsorbed. Other advantages of poly(α-hydroxyacids) utilization in biomedical applications are: possibility of controlling their physico-mechanical properties, chemical or physical modification of their surface properties, ability to immobilize cells or biomolecules within them or on the surface. For this reason they found interesting medical and pharmaceutical applications in the last decades [1] [2] [3] [4] .
The utility of lactic acid polymers based biomaterials in biomedical and pharmaceutical field has generated an enormous research activity, as they offer an attractive combination of mechanical performance, biocompatibility, biodegradability, sterizability, adjustable hydrolyzability, non-toxicity, bioresorption by the organism. These polymers can be synthesized with molecular weights ranging from a few thousands to over a million, being in this way excellent in biomedical applications and are produced from 100% renewable resources, such as corn or sugar beets.
When a biodegradable polymer is used as a matrix carrier in an implantable system, it does not need surgical removal once the drug supply has been depleted. The most useful are copolymers of lactic and glycolic acid, as they combine certain desired properties (biodegradability, biocompatibility, pliability, miscibility with a wide variety of active compounds), their degradation rate can be controlled by modifying the copolymers composition (components ratios), architecture and/or molecular weights, [5] [6] [7] .
Poly(lactic acid) (PLA) is synthesized from lactic acid (LA) monomer as: L(+) or D(-) enantiomers or DL racemic, by polycondensation of LA or ring opening polymerization of lactides. Extensive research has been recently done to improve the polycondensation procedure for a high quality PLA, with controlled architecture and mechanical properties, in high yield and molecular weights that exceed 500,000 Da for stringent requirements of medicine and pharmaceuticals [8, 9] . PLA was first synthesized in 1845 by Pelouze who condensed lactic acid to obtain low molecular PLA and lactide. In 1932 Carothers (DuPont) produced a low molecular weight product, with poor mechanical properties, by heating lactic acid under vacuum. Cargill Dow began researching PLA production technology in 1987 and production of pilot plant quantities in 1992. Only in 1997 Cargill Dow LLC brought two large companies together to focus on the production and marketing of PLA with the intention of significantly reducing the cost of production and making PLA a large volume plastic [10] .
The present paper is not intended to be a comprehensive review on lactic acid polymers field, rather an attempt to emphasize recent research studies on lactic acid polymers synthesis, properties and biomedical applications.
Poly(α-hydroxy acids) in biomedical applications
Poly(α-hydroxy acids) ( O CHR CO ) n , biomedical polymers synthesized fromhydroxy acids (glycolic acid, lactic acid, malic acid) or cyclic dimers and their copolymers with D,L-lactide, glycolide, trimethylenecarbonate, -caprolactone, -valerolactone are mostly utilized in a great number of clinical applications: tissue engineering (soft tissue replacements, blood vessels, kidney membranes, surgical suture implants and scaffolds), skeletal systems (bone plates for fracture fixation, artificial tendons and ligaments), cardiovascular devices (vascular prostheses, heart valves, cardiopulmonary by-passes, or arteriovenous shunts), artificial organs (heart, kidney, liver), ophthalmology (intraocular or contact lenses), dental implants, controlled drug delivery systems [11] [12] [13] [14] [15] [16] [17] . These biodegradable polymers do not evoke a sustained inflammatory or toxic response upon implantation in the body; their degradation time can match the healing or regeneration process, they can have appropriate permeability and processability for the intended biomedical application. A biomedical device should be non-toxic, biocompatible, with good physical and mechanical properties. The last requirement is divided in mechanical performance and mechanical durability: a hip prosthesis must be strong and rigid, a tendon material and an articular cartilage substitute must be strong and flexible. Potentially, devices made from bioresorbable polymers can overcome problems associated with metal implants such as: stress protection, potential for corrosion, as well as the necessity of implant removal. Poly(α-hydroxy acids) degrade by hydrolysis of ester linkages into low molecular weight molecules that can either be metabolized or cleared through the renal system [18] . In addition, they can be readily processed into a variety of structures, while retaining high compressive modulus, being consequently suitable for bone tissue engineering applications. For the purpose of tissue engineering, the polymer must be processed into an open porous structure that fills the tissue deficit while permitting infiltration and development of a new tissue [19] . It is anticipated that the scaffold structure will resorb, leaving behind only new tissue [20] .
Tissue engineering may provide an alternative to treat the loss or malfunction of a tissue or organ without limitations of current therapies. Tissue engineering is the regeneration of functional tissue using cells and a polymeric template. It offers the possibility of using donor cells to engineer replacement tissue. However, the evolution of cells into functional tissue is governed by many factors including template material characteristics, cell source and biological environment. Tissue engineering can be defined as the application of scientific principles to the design, construction, modification, growth, maintenance of living tissues. It can be divided into two broad categories: i -in vitro construction of bioartificial tissues from cells isolated by enzymatic dissociation of donor tissue and ii -in vivo alteration of cell growth and function. The first category of applications includes artificial tissues (i.e tissues that are composed of natural and synthetic substances) to be used as an alternative to tissue transplantation. For tissue engineering in vivo, the objective is to alter the growth and function of cells in situ, an example being the use of implanted polymer tubes to promote growth and reconnection of damaged nerves [21] . During the process of new tissue regeneration, the cellular affinity of the polymer matrix is dependent on the surface properties such as: hydrophilicity, morphology, chemical composition, surface charge. Cell transplantation using biodegradable synthetic extracellular matrices offers the possibility of creating completely new tissues and so replacing lost of malfunctioning organs or tissues. Repair/regenerate damaged tissues is the new trend in tissue engineering instead of implanting permanent devices; a temporary support is provided using a biodegradable polymer until the body can regenerate the damaged tissues [22] . Synthetic extra-cellular matrices achieved from poly( -hydroxy acids) play an important role in the formation of functional new tissues for transplanted cells. Poly(α-hydroxy acids) could be fabricated into scaffolds for cell attachment and proliferation in tissue engineering [23] .
The most often utilized biodegradable synthetic polymers for 3D scaffolds in tissue engineering are PLA, PGA as well as PLGA copolymers. The chemical structure of these polymers allows hydrolytic degradation. Once degraded, the monomeric components of each polymer are removed by natural pathways. The body already contains highly regulated mechanisms for completely removing degradation products: lactic and glycolic acids.These non-toxic degradation monomers can enter the tricarboxylic acid cycle, after which are excreted as water and CO 2 . Tissue engineering has also been proposed for the treatment of cartilage defects. For large irreparable lesions, an implantation in a preformed state may however be required. Their development for treatment of large bone defects would provide attractive alternatives for autografts, allografts, non-degradable polymers, ceramics, or metals that have been currently used in clinical settings [24] .
Low average molecular weight poly( -hydroxy acids) (usually no more raised than about 10,000) could be obtained by direct thermal polyesterification methods [25] . These polymers have not found a practical use in biomedical applications because of very poor mechanical properties. Poly( -hydroxy acids) with higher molecular weights can be produced under controlled conditions, by ring opening polymerization of cyclic dimers (ROP) in the presence of catalysts and exhibit good predictable and reproducible mechanical (tensile strength, elastic modulus), thermo-physical properties and satisfactory degradation rate [26] . Other advantages of ROP over polycondensation procedure, as a commercially viable process are: milder reaction conditions, shorter reaction times, the absence of reaction by-products and the ability of using even six or seven membered cyclic lactones. The most extensively studied monomers for aliphatic polyester synthesis in biomedical applications are: lactide, glycolide and caprolactone (Fig. 1) . Enzymatic polyesterification is another method for developing aliphatic polyesters. It is advantageous, as the reactions can be carried out under moderate conditions and enzymes can also realize high regiospecificity as well as high stereospecificity that conventional catalysts can never achieve [27] . Previous efforts to solve the problem in engineered vascular grafts have led to the application of biodegradable polymers for in vitro generation of an autologous tissue construct. A synthetic biodegradable scaffold consisting of poly(glycolic acid) fibers was first seeded with fibroblasts and then subsequently coated with endothelial cells. The cell labelling experiments demonstrated that in the tissue-engineered heart leaflet, transplanted autologous cells generated proper matrix on the polymer scaffold in a physiological environment at a period of 8 weeks after implantation [28] . However, the affinity between poly(α-hydroxy acids) and cells is not good due to the lack of natural recognition sites of the cells on the surface of the polymers. Many efforts have been made to improve the cellular affinity of poly(α-hydroxy acids). Functional groups such as amino and carboxyl groups could provide recognition sites for cell attachment. To improve the cellular affinity of poly(α-hydroxy acids), some studies have carried out copolymerization of α-hydroxy acids with multifunctional substances such as amino acids [29] [30] [31] [32] [33] . The time required for complete degradation is dependent on their molecular structure, morphology, average molecular weight, size and shape [34] . It is well-known that poly( -hydroxy acids) degrade rather slowly due to their hydrophobic character. It was reported that their degradation rate increased when they were grafted to flexible, hydrophilic poly(ethyleneoxide) (PEO) [35] . The amphiphilic copolymers comprising PEO and hydrophobic polyester segments could be used as matrices in various controlled release systems. In these matrices, poly( -hydroxy acids) such as PLA create the hydrophobic crystalline hard blocks of the copolymer, while flexible hydrophilic PEO represents the amorphous macromolecular chain of the system. The degradation rate of these copolymers could be tailored by altering the copolymer ratio of the components.
A postfabrication encapsulation technique was developed for loading model protein drugs into an intelligent and biodegradable hydrogel film, which exhibits negative thermosensitivity with a desirable phase transition temperature [36] .The hydrogel comprises mainly poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer (PEO-PPO-PEO), and oligo(lactide) (PLA) (Fig. 2) . The model proteins Hemoglobin and Bovine Serum Albumin were loaded into the hydrogel films by soaking the gels at 4 0 C, at which the hydrogel film was swollen, and the loaded drug could be completely released. It was confirmed that proteins, in their native structures, could be included in the hydrogel structure being ideal for drug delivery systems. A new integrated extrusion/jetting and phase separation process could fabricate scaffolds with porous structures, creating a wonderful environment for the growth of new tissue. The macrocellular, microcellular morphology, porosity and mechanical properties of poly( -hydroxy acid) composite scaffolds prepared by this method were investigated and would potentially play an important role in tissue engineering [37] . Some disadvantages of poly( -hydroxy acids) in tissue engineering are: poor biocompatibility, release of acid degradation products, poor processability and loss of mechanical properties during degradation.
Among biomedical polymers, poly(α-hydroxy acids) derived from lactic and glycolic acid proved to be most successful in the field of orthopaedics [38] . Controlled release delivery systems enhance the safety, efficacy and reliability of drug therapy. Poly(α-hydroxy acids), as matrices can regulate the drug release rate and reduce the frequency of drug administration. In drug delivery systems, by modifying the molecular weight of polymer matrices and the components ratio, it is possible to modulate the degradation rate of the polymer and consequently control the release of drugs. Injectable microsphere formulations as well as implantable rods and pellet devices using poly(α-hydroxy acids) were investigated for encapsulation of antibiotics, antiimflammatory compounds, antineoplasic agents, bioactive macromolecules (proteins, peptides). Optimization of these biomaterials properties can be achieved by copolymerization or blending [22] .
Also, targeted release systems were achieved using amorphous polymers of D,Llactic acid as carriers in the form of: microparticles, nanoparticles, micelles, hydrogels; the drugs were directed to the specific cell, tissue or organ where they were afterwards delivered. The specific site delivery of a drug increases its concentration at the tumor site, while decreasing its toxicity by lowering doses that have to be administered in order to achieve the required therapeutic effect. The main advantages of controlled drug release systems are: dramatic decrease in dosing frequency and improved patient compliance, minimized in vivo fluctuation of drug concentrations, localized drug delivery and reduced side effects [39] . The attachment of a drug to a macromolecular carrier alters the rate of excretion from the body and provides the possibility of sustained release over a prolonged period. Drugs formulated in controlled delivery systems are released by: diffusion, swelling, degradation/solubilization or chemical splitting and are administrated by the oral route, parenteral, ocular and nasal way, intragastric or transdermal [40] .
Poly(glycolic acid) (PGA) is the simplest linear aliphatic poly( -hydroxyacid) and was firstly used to develop totally synthetic absorbable suture, that has been marketed as DEXON since 1960 [41] . The ring opening polymerization of glycolide yields highmolecular-weight materials with about 1-3% residual monomer. Fibers from PGA exhibit high strength and modulus, but are too stiff to be used as sutures except as braided material. Sutures of PGA lose about 50 % of their strength after two weeks and 100 % at four weeks and are completely absorbed in 4-6 months [42] . However, these materials are hydrophobic and are processed under quite stringent biologically adverse conditions, which usually make factor incorporation and attachment or entrapment of cells difficult. Copolymers of glycolide with trimethylene carbonate (TMC) called polyglyconate (Fig. 3) have been prepared as both sutures, tacks and screws. These materials have better flexibility than pure PGA and are absorbed in about seven months [16] . Polyglycolic acid (PGA) fiber meshes are also attractive candidates to transplant cells, but they are incapable of resisting significant compression stresses. To stabilize PGA meshes, atomized solutions of poly(L-lactic acid) (PLLA) and a 50:60 copolymer of PLGA, dissolved in chloroform were sprayed over meshes formed into hollow tubes [43] . The PLLA and PLGA coated PGA fibers and physically bonded adjacent fibers. The compression resistance of devices increased with the extent of bonding, and PLLA bonded tubes resisted larger compressive forces than PLGA bonded tubes. Tubes bonded with PLLA degraded slower than devices bonded with PLGA. Implantation of PLLA bonded tubes into rats revealed that the devices maintained their structure during fibro vascular tissue ingrowths, resulting in the formation of a tubular structure with a central lumen. The potential of these devices to engineer specific tissues was exhibited by the finding that smooth muscle cells and endothelial cells, seeded onto devices in vitro formed a tubular tissue with appropriate cell distribution.
Poly(α-hydroxy acids) are also widely used in the pharmaceutical field to prepare micro or nanoparticles allowing the controlled release of drugs [44] . In vivo, the polyester matrices undergo chemical degradation (hydrolysis process), producing totally bioresorbable end-products. By playing on polymer specificities (molecular weight, components ratio), it is possible to modulate the degradation of polymer micro or nanoparticles and thus control with time the release of encapsulated drug [45] .
Poly(malic acid) (PMLA) is a carboxylic-functionalized polyester that may be produced by chemical synthesis or by biological fermentation of myxomycetes and certain filamentous fungi (Fig. 4) . PMLA is a perfectly biodegradable and biocompatible polymer, with exceptionally good features to function as a drug carrier to which tissue-specific tags can be covalently attached. A new prototype poly( -L-malic acid) ( Mw =50,000, Mw / Mn =1.3) derived drug delivery system was tested for its ability to accumulate in tumors, based on enhanced permeability and retention effect and receptor mediated endocytosis. The polymer was tested for targeted delivery of morpholinoantisense nucleotides into ceratin tumors. In brain tumors of nude mice, the drugs accumulated selectively in 24 h without any detectable signal in non-tumor areas. The results of imaging experiments showed specific and significant accumulation of the nanoconjugate DDS in brain and breast tumors [46] .
Lactic acid and lactic acid polymers synthesis

Lactic acid
Lactic acid (LA), the most widely occurring in nature -hydroxy acid, with chemical formula C 3 H 6 O 3 was discovered a long time ago, in 1780 from sour milk and first produced commercially in 1881 [47] . The constitutional structural unit of PLA is LA (2-hydroxy propionic acid), an optically active monomer, which as mentioned exists either as L(+) or D(-) optical isomer (R, S respectively) (Fig. 5) , or racemic mixture (D,L). L(+)-lactic acid is produced in humans and other mammals [48] , whereas both D(-) and L(+) enantiomers are produced in bacterial systems.
Lactic acid enantiomers are mostly produced by fermentation of renewable resources as sugars: glucose, maltose and dextrose (from corn or potato starch), sucrose (from cane or sugar beet), lactose (from cheese whey), starch or lignocellulose (from corn cobs and woody materials) [49] .
Chemical synthesis route gives large quantities of racemic lactic acid mixture, but is economically unviable. Since elevated levels of the D(-)-isomer are harmful to humans, L(+)-lactic acid isomer is the preferred one for food related and pharmaceutical industries. The commercial process of chemical synthesis is based on lactonitrile, derived from acetaldehyde and hydrogen cyanide, obtained by petrochemical process. Hydrogen cyanide is added to acetaldehyde in the presence of a base to produce lactonitrile. The crude lactonitrile is recovered and purified by distillation. It is then hydrolyzed to lactic acid either by HCl conc. or by H 2 SO 4 to produce corresponding ammonium salt and lactic acid. Lactic acid is then esterified with methanol to produce methyl lactate, which is removed and purified by distillation and hydrolyzed by water under acid catalyst to produce lactic acid and methanol, which is recycled. The chemical synthesis route that produces a racemic mixture of D (-) and L(+)-lactic acid is represented by the following reactions [50] The sour milk products, where lactic acid was found were koumiss, leban, yoghurt and some cheese; it was also found afterwards in wheat beers. Its use in food preservation and processing and as a specialty chemical has grown over years with current production of about 120,000 t yr -1 . Its potential as a major chemical feedstock, derived from renewable carbohydrates by sustainable technologies to make plastics, fibers, solvents and oxygenated chemicals, has been recognized. Actually, LA is under increasing demand in pharmaceutical, cosmetic and chemical industries and for production of lactic acid polymers. Since LA is classified as GRAS (generally recognized as safe) for use as a food additive by US FDA, it is also utilized in the food industry, where it serves as flavouring and mineral fortifier. LA is also used as an emulsifying agent in bakery and technical grade lactic acid as acidifying agent in tannery and in small scale applications like: pH adjustment, hardening baths for cellophanes, food packaging, lithographic and textile printing developers, adhesive formulations, electroplating, detergent builders. In pharmaceutical and cosmetic applications, it is found in ointments and lotions for its antimicrobial activity [52] .
In the chemical industry, lactic acid is a raw material for production of lactate ester, propylene glycol, 2,3-pentadione, propionic and acrylic acid, acetaldehyde and dilactide [53] . Nowadays, LA is an important monomer in PLA synthesis, a good substituting derivative of conventional plastics produced from petroleum because of low emission of carbon dioxide. It is soluble in water and water miscible organic solvents but insoluble in other organic solvents and has low volatility.
In the last years the production of lactic acid has increased, due to growing demand of polylactic acid in the biodegradable polymer markets as well as in the chemical sector, food industry.
Lactic acid polymer synthesis
Poly(lactic acid) (PLA) or polylactides (PLLA, PDLA, PDLLA) are thermoplastic, high strength, high modulus poly( -hydroxy acids), biodegradable, biocompatible, nontoxic, especially used either in packaging or medical field.
Lactic acid based polymers can be synthesized by two different polymerization routes: ring opening polymerization of lactides (polymers synthesized are generally referred as polylactides (PLLA, PDLA or PDLLA), or polycondensation of lactic acid (polymers are generally referred as PLA [54] . The polymerization process requires a high purity monomer, as impurities hinder reaction and reduce the quality of polymer. Ring opening polymerization is used to prepare high molecular weight polymers, with short reaction time, under mild conditions. Polycondensation requires high temperatures and long reaction times, polymers have low average molecular weights (maximum values are 30,000 Da). The routes generally used for LA polymers syntheses are presented in Fig. 6 : oligomerization and ring opening polymerization, azeotropic condensation polymerization, solid state polymerization, direct condensation polymerization. The properties of lactic acid based polymers vary to a large extent and depend on the ratio and distribution of LA optical isomers [55] . -Lactic acid polymer synthesis by polycondensation Lactic acid is generally melt condensation polymerized, with or without a catalyst, while vacuum and temperature are progressively increased, to achieve a low molecular weight, brittle, glassy polymer, which must be afterwards modified with chain extending agents to increase its molecular weight [56] [57] [58] . The stereoregularity cannot be controlled during polycondensation and the polymer has inferior mechanical properties. Lactic acid polycondensation with Sn(II)-ethylhexanoate as a catalyst produced a quite high molecular weight polymer ( Mn =28,200 g/mol), but it was totally amorphous (the proportion of D(-) lactic acid units was about 48 mol %). Also, byproducts were obtained (lactide, water, lactic acid oligomers) and polymer production stopped when equilibrium was reached [59] . Consequently, solvents with high boiling point were used for efficient water removal, by means of azeotrope distillation technique. As in biomedical applications PLA with raised molecular weights is utilized, PLA prepolymer ( Mn =10,000-50,000) was afterwards extruded under heating and vacuum, free water was distilled off and lactide and low molecular weight compounds of lactic acid were selectively removed as the reaction proceeded, polymer with molecular weight of at least 100,000 was obtained [60] . The properties and molecular weights of lactic acid polymers could be improved, using selective chain-extending agents ( Fig. 7) and by modifying the polycondensation parameters [59] .
The molecular weight of lactic acid polymers synthesized by polycondensation procedure is low due to the presence of water impurities (it is difficult to remove them completely from the highly viscous reaction mixture), low concentration of reactive end-groups, "back-biting" equilibrium reaction that forms the six-member lactide ring. The condensation polymerization is the least expensive route, but by conventional procedure is impossible to obtain high molecular weight products, therefore the use of chain extending agents is required, adding cost and complexity.
Azeotropic condensation polymerization is a new procedure utilized to achieve high average molecular weight PLA (up to 300,000), without use of chain extenders, but with an adequate catalyst and appropriate azeotropic solvent [61, 62] ; also high molecular PLA is obtained by direct dehydration polycondensation [63] . BOX-2,2 -bis(2-oxazoline); EO%-lactic acid oligomer; PEUA-poly(esterurethaneamides); E1%, E2%, E4%-lactic acid oligomer with 1,2,4 mol% BD; ESA2%-lactic acid oligomer with 2 mol% SA; PEU1%H, PEU2%H, PEU4%H-1,6-hexamethylene diisocyanate based poly(ester-urethane); PEU4%B-1,4 butane diisocyanate based poly(ester-urethane).
Solid state polymerization (SSP) is also a new method to obtain high molecular weight PLA (500,000 Da), but it requires temperatures above its glass transition temperature (to allow mobility of the end groups to react) and below the melting temperature, the reaction time required is much longer than for polycondensation in melt or solution. The procedure involves heating of the semi-crystalline solid PLA prepolymer up to a temperature below the melting temperature, with simultaneous removal of byproducts from the surface of the material (by volatilizing under reduced pressure or with a carrier, blowing inert gas) (Fig. 8 ) [8] . The advantages of SSP are low operating temperatures with control of side reactions as well as of thermal, hydrolytic, oxidative degradation, improved physico-chemical properties of homopolymer, as monomer cyclization and side reactions are limited. A high quality polymer could be obtained in high yield, in a relatively short reaction time and its molecular weight exceeded 500,000 Da.
Sequential melt-solid polycondensation of lactic acid (LA) produces high molecular weight poly(lactic acid) (PLA), which is cost effective and can be put to a variety of uses,including packaging, biomedical and electrical appliances [64] . The technology available for melt as well as solid state polycondensation of LA, the selection of catalysts, the effects of operating parameters on the molecular weight of the product and various PLA properties (physical, thermophysical, mechanical, electrical), degradation behavior and their dependence on the molecular weight of the product were recently studied. The kinetics and mechanisms involved in the different synthetic methods and degradation of the polymer were also discussed. A response optimization analysis used in the design of experiments suggested a group of parameters under which one could achieve higher molecular weight PLA, and provided mathematical relationships between synthesis parameters and molecular weight. . Lactic acid polymers with almost the same properties as those prepared by ring opening polymerization of lactides were obtained in two-step reaction: firstly lactic acid was condensation polymerized in the presence of difunctional monomers (e.g. diols or diacids) and telechelic prepolymers were synthesized [65, 66] . They were afterwards chain-linked in a second reaction step, using monomers as: isocyanates, bisoxazoline or bis (amino-ether), yielding high molecular weight polymers [67] .
-Lactic acid polymers synthesis by ring opening polymerization Lactic acid polymers synthesized by ring opening polymerization of lactide are the most studied ones, as they have a high degree of stereoregulation, their properties can be varied in a controlled manner, the molecular weight is high ( Mn 10 5 ).
As lactic acid exists in two different optically active isomeric forms, three different lactides can be obtained The ring-opening polymerization of lactide has been performed as melt, solution, bulk or suspension polymerization and comprised ionic (cationic, anionic) or coordination insertion mechanisms, depending on the catalyst utilized [68] [69] [70] . Catalysts employed were metal powders, Lewis acids, Lewis bases, organometallic compounds, salts of different metals. Organometallic compounds are very effective, particularly alkylmetals, metal halides, oxides, carboxylates and alkoxides [70] , transition metal compounds of tin [71] [72] [73] [74] , zinc [75] , bismuth [76] , iron [77] , yttrium [78] . When Sn(Oct) 2 is used, it has been proposed that the catalyst reacts with the alcohol and is converted to tin alcoxides, which are active species in polymerization [84, [86] [87] [88] . MALDI-TOF mass spectroscopy revealed that macromolecules contained tin alkoxide species in the polyester chain. The coordination insertion mechanism was postulated for the catalytic activity of Sn(Oct) 2 , which involved conversion into tin alkoxide bond and subsequent cleavage of acyl-oxygen bond of lactide. It was also reported that the rate determining step in the coordination-insertion mechanism is the nucleophilic attack of tin alkoxide on the carbonyl carbon of the monomer [89] . After Sn(Oct) 2 has been converted to tin alkoxide, no additional active polymerizing centers were present, providing that the [Sn] 0 level remained constant. Thus, the combined kinetic and spectroscopic data showed that Sn(Oct) 2 was by itself neither an initiator nor a catalyst of LA polymerization; the reaction of Sn(Oct) 2 with ROH (coinitiator: alcohol, hydroxy acid, H 2 O, macromolecule fited with a hydroxyl end group) provided the initiating species. It was concluded that L,L-dilactide/SnOct 2 polymerization proceeded by simple monomer insertion into the Sn-OR bond, reversibly formed in the reaction [84] . Kowalski and coworkers [90] reported also on the mechanism of L,L-lactide or -caprolactone (CL) ring opening polymerization initiated by Sn(Oct) 2 in the presence of primary amine systems. The mechanism of polymerization did not differ appreciably from that coinitiated with alcohols.
Other advantages are related to its commercial availability and high selectivity even in bulk, high temperature polymerization. Reaction parameters in polymerization are: 0 C, Sn(Oct) 2 concentration 100-1000 ppm and reaction time 2-5 h to reach 95 % yield [80] . In lactides polymerization using Sn(Oct) 2 and alcohols, studies demonstrated that alcohol increased polylactides production rate, higher alcohol concentration lowered the polymer molecular weight [79] . PDLLA designed to serve as resorbable materials for medical or pharmaceutical applications is usually prepared using Sn(Oct) 2 , as it is a highly efficient catalyst, high molecular weight products are obtained, but the polymers are amorphous, the process is rather complicated and production costs are expensive. The mechanism of cyclic ester polymerization using Sn(Oct) 2 has been studied a long time and was much disputed for almost 15 years. The mechanism and polymerization variables (polymerization temperature and time, monomer/catalyst ratio) were much studied with considerable debate about the true mechanism [80] [81] [82] . There were suggested different polymerization mechanisms with Sn(Oct) 2 [10, 54, 70, 71, 73, 74, 83, 84] and a recent and verified coordination insertion one is given in Fig. 11 [85] .
The kinetics and mechanism of L,L-dilactide polymerization, initiated with tin(II) butoxide [Sn(OBu) 2 ] and carried out in THF solvent (20 -80 0 C), or in bulk (at 120 0 C), were also studied. Polarimetric and size exclusion chromatography (SEC) measurements showed that initiation was fast and intramolecular transesterification (back-bitting reactions) were not observed. According to 1 H NMR and MALDI-TOF spectra analyses, both alkoxide groups in Sn(OBu) 2 were converted into poly(Llactide) growing chains, and monomer addition proceeded with acyl oxygen bond scission (Fig. 12) [91] . As previously mentioned, a great deal of metal complexes are exploited to initiate lactide polymerization, but the most active metal compounds included Mg(II), Ca(II), Sr(II), Ba(II), Sn(II), Al(III), Zn(II) and lanthanide (II) complexes [92] [93] [94] .
In the latest researches, new organocatalytic systems are described such as: thiourea, guanidine or amidine [95, 96] . The average molecular weights of the resulting polyesters were almost equal to 8. 5 10 4 . In the paper of Pratt and coworkers [98] , thiourea-amine catalysts and mild conditions in ROP, lead to shorter polymerization times, better control of microstructure and polymers with predictable molecular weights. The carbonyl group of a lactide monomer was activated toward electrophilic attack by the thiourea via hydrogen bonding, and the initiating/propagating alcohols were activated as nucleophiles by the tertiary amine. This mechanism does no t involve ions and is presented in Figure 13 .
Semicrystalline optically active PLLA retaining 95. catalysts used led to the synthesis of crystalline, optically active PLA without significant racemization The polymerizations were performed using different molar ratio of monomer to initiator and different reaction times [97] . In biomedical applications, salts and complexes of metals such as Al, Cd, Pb, Zr, Y as initiators, should be avoided (Al 3+ is under suspicion to favour Alzheimer disease).
Unfortunately Na, K, and Ca salts or complexes which may be useful as initiators are so basic that they cause deprotonation of lactides in α-position. The consequences are partial racemization and chain-transfer reactions which strongly limit polymers molecular weights. Research studies concluded that different initiators produced different kinds of polylactides (different degrees of crystallinity and average molecular weights). The main reason for different structures and molecular weights is ester interchange and racemization reactions during polymerization. The studies demonstrated that Bi salts are less toxic than many other metal salts (including Zn), against kidney tubes which are particularly sensitive to poisoning by heavy metals.
Supercritical carbon dioxide (scCO 2 ) attracted much attention in recent years as a replacement of traditional organic solvents. Supercritical carbon dioxide determines lack of toxic solvent residues in the product and ease of product recovery by simply venting of the reaction vessel. Ring-opening polymerization of L-lactide in scCO 2 gives products with acceptable molecular weight and yield, without catalysts and solvents that can pose risks when such materials are in contact with biological fluids [98] .
A reactive extrusion polymerization process was developed, based on a new catalytic system that produced PLA in larger quantities and at lower costs. The reactive extrusion polymerization enhanced the ring opening polymerization kinetics of Llactide and also suppressed side and degradation reactions, such as intermolecular transesterification reactions [99] .
Physical properties of lactic acid based polymers
Thermophysical properties
Thermal characteristics of polylactides: glass transition temperature (T g ), melting temperature (T m ) and degradation behaviour have been determined [100] . PLLA is a partially crystalline polymer (degree of crystallinity 45-70 %), T g 328 K, T m 453 K, crystallisation temperature (T c ) 463 K, and decomposition temperature (T d ) 458 K The degree of crystallinity and T m of PLLA decrease with decreasing optical purity and PLLA of less than 87.5 % optical purity is amorphous; PLLA of high optical purity has similar T m to that of other polymers with methyl side groups, as microbial poly(hydroxybutyrate) (PHB) and isotactic polypropylene (i-PP). An optical purity of at least 72-75 %, corresponding to about 30 isotactic lactyl units was required for PLA crystallization to take place [101] . The melting temperature and degree of crystallinity of PLA are dependent on the molar mass, thermal history, purity of the polymer. The crystallization kinetics and melting behaviour of PLLA of different optical purities were much investigated [102] [103] [104] [105] [106] . The heat capacity of PLA is reported from T = 5 to 600 K as obtained by differential scanning calorimetry (DSC) and adiabatic calorimetry [107] . The experimental heat capacity of liquid PLA was expressed by Cp (liquid) =120.17+0.076T J•K -1 •mol -1 . The glass transition temperature of amorphous PLA occurs at T=332.5 K with a change in heat capacity of 43.8 J K -1 mol -1 . Depending on thermal history, semi-crystalline PLA has a melting endotherm between T= 418 and 432 K with variable heats of fusion. For 100 % crystalline PLA, the heat of fusion is estimated to be 6.55 ±0.02 kJ mol -1 at T=480 K.
Poly(lactide)s with different optical purities were synthesized by copolymerization of D-lactide and L-lactide. Crystallization of D-and L-lactide copolymers before and after 1:1 blending was studied from the melt over a wide range of annealing temperatures (T a ), using DSC and polarizing microscopy [106] . Melting temperature and crystallinity increased with an increase in optical purity for both the no blended and the 1:1 blended PLAs and they lost their crystallinity when their optical purity became lower than 76 %, suggesting that the critical isotactic length of PLA for crystallization was approximately 15 isotactic lactyl units.
The molecular and crystal structure of PLLA was studied by means of potential energy calculations and diffraction methods, AFM, TEM, X-ray scattering [108] [109] [110] [111] [112] . Poly(L-lactide) and poly(D-lactide) crystallize into a stereocomplex with a melting point 320 K higher than of enantiomers. The racemic crystal is formed by packing β-form 3 1 -helices of opposite absolute configuration side by side. A model of stereocomplex crystal growth was proposed, which explained the triangular shape of single crystals. Also, it was found that each of polylactides having optical purities between 43 % and 100 % can crystallize and a correlation was found between the measured melting temperature of optically active polylactides and their average sequence length [113] . Depending on the preparation conditions, PLLA crystallizes in three modifications: -, β-, and -forms.
The melt enthalpy (ΔHm) of enantiopure PLA of 100 % crystallinity has values up to 148 J/g [114] . An interesting attribute of PLA is the ability of enantiomeric blends of PLLA and isotactic PDLA to form a stereocomplex with high crystal stability [115] . Blend of PLLA and PDLA (1/1) produce a stereocomplex with T m of about 500 K.
Copolymerization of L-lactide with other cyclic esters has been recognized as an important tool to modify the properties of lactic acid based polymers and adjust them to the needs of a certain application. As the high crystallinity of PLLA causes a decrease in biocompatibility with soft tissues, copolymerization of L-lactide with comonomers as: glycolide, ε-caprolactone, trimethylene carbonate, δ-valerolactone, 1,5-dioxepan-2-one was much studied, and results demonstrated that thermal properties of copolymers changed [116] [117] [118] . The degree of crystallinity and melting temperature of PLLA can be reduced by random copolymerization of lactides with these comonomers. Copolymers with glycolide are much more hydrophilic than PLLA while ε-CL, TMC lower T g and degree of crystallinity. Also, during long-term hydrolytic degradation at 37 0 C and accelerated degradation experiments, at 100 0 C, it is shown that the presence of crystallizable L-lactide sequences in the copolymers determine long degradation times. Therefore, completely amorphous non-crystallizable copolymers are the preferred materials for use in biodegradable applications.
Number average molecular weight, melt viscosity determinations, DSC, FTIR and TGA were used to study PLA degradation behaviour under different conditions. Polylactides were found to be highly sensitive to heat, especially at temperatures higher than 190 0 C. Most of the degradative reactions involved the highly concentrated ester bonds on the main chain. These reactions included: thermohydrolysis, depolymerization and cyclic oligomerization, intermolecular and intramolecular transesterification. Low molecular weight compounds (water, monomer, oligomer and polymerization catalyst) associated with the polymer, as well as hydroxyl end groups of the main chain seemed to play an important role in lowering the molecular weight of polymers.
Solubility
The solubility of lactic acid based polymers depends on the molar mass, degree of crystallinity and comonomer units present in polymer chain. Enantiomerically pure PLLA dissolves in chlorinated or fluorinated organic solvents, dioxane, dioxolane and furane. Poly(rac-lactide) and poly(meso-lactide) are soluble in many other solvents: acetone, pyridine, ethyl lactate, tetrahydrofuran, xylene, ethylacetate, dimethylsulfoxide, N,N-dimethylformamide, and methylethyl ketone. Nonsolvents for lactic acid based polymers are: water, alcohols (methanol, ethanol, propylene glycol) and unsubstituted hydrocarbons (e.g. hexane, heptane) [65, 119] .
Miscibility with other polymers
PLLA, besides its long degradation time is usually hard and brittle, which hinders its usage in orthopaedic and dental applications. PDLLA can degrade quickly due to its amorphous structure, but has poor mechanical properties. Considerable efforts were done to improve PLLA properties, as it is derived from renewable resources and the quantity of carbon dioxide generated by incineration is much lower than of conventional petrochemical plastics [polystyrene (PS), polyethylene (PE), polypropylene (PP)]. These attempts were carried out by blending PLLA with low molecular weight plasticizers or by blending with other copolymers. Various types of compounds such as: glycerol, ethylene glycol oligomer, citrate esters, glucose monoesters, fatty acid esters, lactic acid oligomer, diglycerine tetraacetate, glycerol triacetate, tributyl o-acetylcitrate, bis(2-ethylhexyl adipate) were reported as plasticizers for PLA. Their effect on molecular, thermal, and mechanical properties of PLA was investigated for content up to 20 wt %. Very good mechanical properties were obtained using plasticizers having lowest molecular mass and best interaction parameter. T g and T m of plasticized PLLA is much lower, the polymer has better resistance to moisture and hydrolysis [120, 121] . PLLA has been blended with different polymers such as :poly( -caprolactone) (PCL), poly(hydroxybutyrate) (PHB), poly(vinyl acetate) (PVAc), poly(methyl methacrylate) (PMMA), PEO, PS, PE to improve its properties like degradation rate, permeability characteristics, drug release profiles, thermal and mechanical properties [122] [123] [124] [125] .
In order to improve the mechanical properties of PDLLA for bone repair, it was blended with poly(3-hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx). Blends consisting of PDLLA and PHBHHx at 2:1 and 1:2 ratios exhibited lower elastic modulus and higher elongation at break than unblended PDLLA [126] .
Mechanical properties
For PLA applications in medicine, certain structural and mechanical properties are required. In some applications as guided tissue regeneration, isolation of the wounded area during the healing process is required. Therefore, devices with dense structures are preferred over porous ones, as the polymer implant will function as a barrier to allow the growth of specific tissue and to obstruct the migration of other tissues that disturb the healing process. In cell scaffolding, for transport of nutrients and oxygen of the cells, pores are required.
Semicrystalline lactic acid polymers have approximate tensile modulus of 3 GPa, tensile strength of 50-70 MPa, flexural modulus of 5 GPa, flexural strength of 100 MPa and elongation at break of about 4 %, being more useful than amorphous polymers in load-bearing applications such as orthopaedic fixation and sutures [127] . The molar mass and degree of crystallinity have a significant influence on mechanical properties of lactic acid polymers [128] . To increase the tensile strength and modulus of PLLA and of its blends and copolymers with PDLA and PCL, fiberspinning was employed. For both melt and solution spun fibers the highest mechanical properties were obtained [129] .
By copolymerization of LA with ε-CL, copolymers with a lower tensile strength, increased elongation and higher impact were achieved, as compared to PLA homopolymers and PLGA [130] . In medical applications PLLA of high molar mass has sufficient strength for use as load bearing materials, but it degrades slowly due to reinforcing crystalline domains. PLLA crystallinity can be reduced by copolymerization of L-lactide with D-lactide; an amorphous rac-PLA with a faster degradation profile can be obtained [131] . Copolymerization of L-lactide with small amounts of increased D-lactide also the impact strength of the copolymers. The higher values of the impact strength of PLLA networks chemically cross-linked with spiro-bis-dimethylene carbonate (spiro-bis-DMC) in comparison to the copolymers of L-lactide with D-lactide are attributed to the presence of chemical crosslinks in addition to the physical ones [132] . The mechanical strength of LA based poly(esterurethane)s were comparable to PLA homopolymers [133] , but could be modified by copolymerization with ε-CL. Poly(ester-urethane)s based on 50/50 poly(lactic acidco-caprolactone) (PLA-co-CL) prepolymers had higher tensile strength (45 MPa) and modulus (60 MPa) compared to high molar mass 50/50 PLA-co-CL [134, 135] .
Also, in order to modify the mechanical and thermal properties and obtain controlled degradation of PLA, chain extending agents were utilized (isocyanates or bisoxazolines) and the high molecular weight polymers synthesized could be used in tissue reconstruction, controlled drug delivery systems, polyurethane foams. PLA based poly(ester-amides) synthesized with 2,2"-bis(2-oxazoline) had improved impact strength, tensile stress and maximum strain compared to poly(ester-urethanes). [136] . Generally, lactic acid can be condensation polymerized directly to low molecular weight telechelic poly(L-lactic acid) polymer. In preparing of telechelic polymers with hydroxyl or carbonyl end groups, L-lactic acid was condensation polymerized with 1,4-butanediol or adipic acid, with tin-(II) octoate as the catalyst [137] . It shoul be noted that these prepolymers must be considered as new starting material in addition type chemistry and not as high molecular weight poly(lactic acid). The use of a difunctional substance allows changes in the balance between the hydroxyl and acid groups, so instead of having equal numbers of functional groups, the added difunctional compound moves the balance toward the desired composition. The glass transition temperatures of the telechelic prepolymers are strongly dependent on the molecular weights. The higher the molecular weights, the higher the glass transition temperatures of these polymers. This conclusion closely fits the theory [138] which says that end groups increase free volume and decrease the glass transition temperature of polymers. In the polymerization of telechelic polymers, the molecular weight of the resulting polymer depends on the amount of difunctional compound added, and the end groups depend on the nature of the compound. These telechelic prepolymer molecules can be linked together using chain extenders such as diisocyanates the resulting polymer is a thermoplastic poly(ester-urethane).139]. The results indicate that high conversions of lactic acid can be achieved, as well as independent control of the stereostructure, long chain branches, molecular weight average, and molecular weight distribution. Lactic acid is converted into a poly(ester-urethane) with a weight average molecular weight as high as 390,000 g/mol and a glass transition temperature of 53.7 o C. The tensile strength (48.7 MPa), yield stress 18.4 MPa and modulus (2300 MPa) of poly(ester-urethane) were very close to the corresponding values for PLA made via the ring-opening route. The mechanical properties were similar, although the number average molecular weight of the poly(ester-urethane) was just one-third of the molecular weight of the PLLA, and a polydispersity index 3.6 times higher.
Other copolymers of L-lactic acid (LLA) with D,L-mandelic acid (DLMA), 4-hydroxybenzoic acid, 4-acetoxybenzoic acid, D,L-malic acid, or anhydrous citric acid were synthesized via direct copolycondensation in the presence of 1,4-butanediol, using stannous octoate as catalyst [140] . The effect of the comonomer and the comonomer ratio on polycondensation and the glass transition temperature were investigated. The glass transition temperature of amorphous poly(L-lactic acid-co-D,L-mandelic acid) increased linearly from 33 o C to 56 o C as the mandelic acid composition was increased from 0 to 45 mol %.
Storey and collab. [141] used ethyl 2,5-diisocyanatohexanoate and poly(ester triols) synthesized from D,L-lactide, -caprolactone, or comonomer mixtures of them, with glycerol as the initiator. Their networks based on poly(D,L-lactide) triols were rigid and the -caprolactone based networks were elastomeric. Copolymer networks were tougher than networks based on the homopolymers. Authors found that networks based on D,L-lactide were most resistant to degradation. Consequently, by modifying the end groups structure of PLA, the mechanical and thermal properties of LA polymers were improved.
Multiblock copolymers poly(ether-ester-urethane)s (PELA) were synthesized by ringopening polymerization of L-lactide, initiated by the hydroxyl terminal groups of the PEO chains, followed by the chain extension of the PLA-PEO-PLA triblocks, using hexamethylene diisocyanate (HMDI) [142] . They exhibited superior mechanical properties, with ultimate tensile strength values around 30 MPa, Young"s modulus as low as 14 MPa and elongation at break values above 1000 %.
Degradation
The hydrolytic degradation of LA based polymers is beneficial in medical devices and in compostable packages. The hydrolysis of aliphatic polyesters starts with a water uptake phase, followed by the hydrolytic splitting of ester bonds in a random way. The amorphous parts of polyesters undergo hydrolysis before the crystalline regions because of a higher rate of water uptake. The remaining undegraded chain segments obtain more space and mobility, leading to reorganization of polymer chains and an increased crystallinity [143] . In the second stage of hydrolysis, the hydrolytic degradation of crystalline regions of the polyester leads to an increased rate of mass loss and finally to complete resorption. Under dry conditions, pure PLA can last more than 10 years, in the case of copolymers it depends on their composition [144, 145] . The degradation mechanism of PLA is believed to occur mainly through random chain scissions of the ester group in the main chain, causing a gradual decrease in the number average molecular weight. PLGA copolymers are hydrolysed much faster than PLA and have become the main biodegradable polymeric materials in sutures, implants, tissue engineering and drug release when fast rate of hydrolysis are desirable, whereas poly(lactide-co-caprolactone) are more suitable for slower hydrolysis rate applications [146] . The hydrolytic degradation of copolymers of Llactide and ε-caprolactone was reported to proceed fastest for molar ratios of lactide/caprolactone in the range of 50/50 to 30/70 [147] . Also, copolymers of trimethylene carbonate and rac-lactide degrade faster than rac-lactide homopolymers, with increasing amount of ester linkages incorporated [148] .
Concerning stability in biological environment, the biodegradation of lactic acid based polymers was studied in vitro and in vivo, in anaerobic, aerobic or aquatic conditions. A screening study reported the degradation of PLLA in the presence of different enzymes. Researches concluded that pronase, proteinase K, and bromelain had significant effect on the hydrolysis rate and that ficin, esterase and trypsin at a smaller extent [149] . In aerobic aquatic headspace test, the mineralization was very low at room temperature, but faster under thermopile conditions. In aquatic tests, the effect of temperature on PLLA biodegradability indicates that polymer structure has to be hydrolysed before microorganisms can utilize it as a nutrient source. The behaviour of PLLA in the natural composting process was similar to that in the aquatic biodegradation test [150] . The molecular weight, molecular weight distribution of the polymers, ionic strength of the degradation medium and size and shape of the devices subjected to degradation are factors that influence the rate of degradation [151] [152] [153] . The biodegradability of different lactic acid based poly(ester urethane)s was studied by the headspace test method. A significant biodegradation could be noticed at 25 o C and at 37 o C, where 50 % of the polymers were degraded. The degradation temperature as well as the stereostructure and the length of PLA segments in the polymer were the relevant parameters in the degradation process [154] . Different lactic acid based polymers and different low or high molar mass compounds were found to affect the degradation behaviour. The presence of enantiomeric blends of poly(rac-lactide) and poly(D-lactide) as well as the presence of lactic acid and lactoyl lactic acid affected biodegradation [155] . There were done also microbial degradation studies on PLA. Although most microorganisms studied could utilise lactic acid and its dimer, microbial degradation of oligomers and polymers of PLA were not observed at appreciable rates [156] .
Lactic acid polymers and copolymers in drug delivery systems
The advantages of polymer controlled drug delivery are multiple such as: increase of drug efficiency for a given dose, avoid repeat administration, deliver the drug at predetermined doses and rates, to targeted organs and cells.
Controlled drug delivery applications include both sustained (over days/weeks/months/years) delivery and target (e.g. to a tumor, diseased blood vessel) delivery, on a one-time or sustained basis. Controlled release systems were achieved using biopolymers as carriers (microparticles, nanoparticles, micelles, hydrogels) and drugs that could be directed to the specific cell, tissue or site where the drug was afterwards delivered. The history of biodegradable polymers in drug delivery systems dates back to1970 when poly(glycolic-co-lactic acid) was used to control the release of narcotics. Homopolymers of L-lactide and especially D,L-lactide (Fig.14) and copolymers of lactide and glycolide (Fig. 15) were especially used as matrices in systems for delivery of therapeutic agents as: contraceptive steroids, antineoplasic drugs, antimalarial, narcotics, antibiotics, vaccines, peptides, hormones due to their good biocompatibility and biodegradability, degradation rate that could be controlled over a wide range by changing the molecular weight and as they did not require surgical removal [157] [158] [159] Controlled drug release from these systems has been explained by different mechanisms: Fickian diffusion through the polymer matrix, diffusion through water filled pores created upon swelling of the matrix and delivery by erosion of the polymer matrix [160, 161] . The predominant application of PLGA, with good results was in subcutaneous injectable systems in the form of suspended powders, thin rods, or small beads [162, 163] . In PLGA drug delivery systems, lactic acid is most frequently chosen as the predominant component, as it is more hydrophobic and optically active (an additional measure of system design control), but polymers prepared in a 50:50 proportion are hydrolyzed much faster than those with a higher proportion of either monomer [164] .
To overcome the disadvantages of injections with leuprolide acetate (agent that treats steroid-hormone dependent tumors), as the treatment requires once-daily repeated injections of the drug over a long therapeutic period and oral dosages determine fluctuating blood levels, a prolonged release dosage form is preferable. Injectable prolonged-release PLA and PLGA microcapsules were prepared by an in water drying method using a w/o/w emulsion. The drug was completely entrapped by the microcapsules in the range of 10 to 20 wt. % on the basis of the polymer [165] . In vivo and in vitro studies of peptide hormone nafarelin, a potent luteinizing hormonereleasing hormone agonist from PLGA implants demonstrated that the release had a triphasic profile and the primary factor controlling the peptide release was polymer erosion, which could be controlled by modifying the physical properties of the matrix. The mechanism of drug release from PLGA is a combination of diffusion and erosion. As drug on the surface of the device diffuses away, exposed polymer hydrolyses and a greater matrix surface area is exposed. Drug can diffuse through the polymer to the surface. The loss of drug is more rapid than the loss of polymer and the device passes through a very porous stage before it is totally eroded. Generally, hydrophilic drugs with PLGA microspheres presented faster release kinetics than hydrophobic ones [44, 166] . PLGA (50:50) biodegradable microparticles, obtained using the double emulsion solvent evaporation technique with ultrasonication, showed excellent encapsulation efficiency and gentamicin release over 30 days. They are consequently very good candidates for sustained gentamicin release and prevent bacterial osteomyellitis in orthopaedic surgery [167] . Nanoparticles formulated by nanoprecipitation of acid-ended PLGA were found to be able to control the release of doxorubicin in a pH-dependent manner. Nanoparticles delivered the drugs into cells quickly and in higher quantity than when presented in solution and had a better therapeutic efficacy compared to the free drug [168] .
The release profiles of model drugs (propanolol HCl, diclofenac sodium, salicylic acid and sulfasalazine) from low molecular weight PDLLA tablets immersed in buffer solutions were investigated. Drug release was confirmed by diffusion through the polymer matrix and by erosion of the polymer [169] . A biodegradable delivery system based on PDLLA was formulated for sustained release of pefloxacin. The in vitro release of pefloxacin from low molecular weight PDLLA (2 10 3 ) lasted for 56 days whereas in vivo delivery lasted 33 days. In both cases the release rate was controlled by drug diffusion and polymer degradation, which seemed to be the predominant factor [170] . For release experiments, discs were prepared from PDLLA with drug loadings of 2 % and 10 %. The release properties of implants could be adjusted using PDLLA with a molecular weight of 20,000, drug delivery was prolonged to more than five months, systemic side-effects and local tissue reactions were satisfactory post-operatively.
PLGA film-based implants show a considerable potential utility as delivery systems of an antimalaric peptide (SPf66) between several films. 25 % PLGA ( Mw =48,000 Da) dispersions in dichloromethane showed viscous Newtonian behaviour, being easy flowing and adaptable to the moulds. Evolution of viscoelastic properties, polymer molecular weight and SPf66 release pattern from the implants immersed in various media was evaluated [171] .
Paclitaxel-loaded nanospheres of PLGA (D,L-lactic acid/glycolic acid ratio 50:50 or 75:25) were prepared by an improved solvent extraction/evaporation technique, under various fabrication conditions. The in vitro release experiments showed that paclitaxel release could last more than 3 months at an approximately constant release rate after an initial burst [172] .
Block copolymer micelles are core-shell type colloidal carriers and can be utilized for drug and gene delivery. A large amount of drug, to be subsequently released, can be conjugated or encapsulated by them. They show long circulation characteristics and significant passive accumulation in areas with leaky vasculature, such as cancerous tissues and infarct zones. Attachment of targeting ligands, such as antibodies, to their outer surface may enable a targeted drug delivery at specific sites. Micelles loaded with up to 25 % of the anticancer drug "paclitaxel" have been prepared by solution casting method using poly(ethylene glycol)-b-poly(D,L-lactide) (PEG-b-PDLLA) (Fig.16 ). This block copolymer was synthesized by ring opening polymerization of D,L-lactide with PEG-2000, in the presence of SnOct 2 [173] . The anticancer drug adriamycin was loaded into the core of thermoresponsive micelles, formed by a block copolymer obtained by ring opening polymerization of D.L-lactide with poly(N-isopropylacrylamide-co-dimethylacrylamide). The size of micelles and the amount of incorporated drug depended on the temperature of preparation in the dialysis process. When it was conducted at 20-25 0 C, 5-6 wt. % of adriamycin could be incorporated into the 50-75 nm large micelles [174] .
The morphology and degradation rate of PLA matrices in drug delivery systems could be controlled by an appropriate choice of polymer molecular weight and stereochemistry or by copolymerization with other biocompatible monomers: glycolide, -CL and TMC. Blends and copolymers of 1,5-dioxepane-2-one (DXO) and L-lactide (LLA) were prepared and compared in sustained drug delivery systems. As the morphology is a powerful tool to control the release characteristics of the system, results demonstrated that blends formed denser and less porous microspheres with a higher degree of matrix crystallinity than copolymers of LLA-DXO, but sustained delivery was obtained from both copolymers and blends [175] . Small cylinders of low molecular weight PDLLA ( Mn =1400) (100 % in vivo degradation at 5th week of implantation) and high molecular weight PDLLA ( Mn =11500) blends have been studied for the prolonged release of hydrophilic drugs, i.e. a luteinizing hormonereleasing hormone agonist (LH-RH agonist) [176] . Results demonstrated that the drug release was dependent on the amount of high molecular weight PDLLA used, the best efficacy and most constant release over a long period were obtained when a 25/75 % low Mw-PDLLA/ high Mw-PDLLA blend was utilized. The release and biodegradation of the antibiotic Norfloxacin, which was used against eye irritation from surfactant-free PLG nanoparticles was investigated. The size of nanoparticles depended on the solvent used for their preparation and the rate of their degradation was size-dependent [177] . Also PLA was used in release devices for vaccine delivery. Multidose pulsatile delivery system was developed and release kinetics was investigated from a polylactide albumin reservoir system. Albumin pellets were coated with polylactide of different average molecular weights ( Mv ) and concentration and incubated in aqueous solution. The albumin release profile was approximated zero order release kinetics, with release rates from 3-1800 mg/day. The permeability of PDLLA membrane to albumin diffusion ranged from 1 10 -9 to 100 10 -9 cm 2 /s and decreased with increase of membrane thickness (18-1400 m) and density (300-3000 mg/cm 3 ). The initiation of albumin release from pellets could be delayed from a few hours to more than one month by increasing the molecular weight of polylactide from 6.2 10 3 to 140 10 3 and raising polymer coating solution from 50 to 100 mg/ml [178] .
Amphiphilic block copolymers have been widely studied in controlled drug delivery systems, as they are capable of forming aggregates of a hydrophobic core and a hydrophilic shell (drug delivery systems require materials with a variety of hydrophobicities/hydrophilicities to improve the affinity with various kinds of drugs or tissues). In these applications, sometimes PLA is too hydrophobic and its degradation rate is too slow. Block copolymers of PLA, PLGA, PCL matrices with hydrophilic chains are also of particular interest in the manufacture of drug delivery systems, as they present better physico-mechanical properties, water absorption, polymer degradation, polymer-drug and polymer-organism interactions. These matrices are adequate in drug delivery systems, as they can deliver not only hydrophobic but also hydrophilic drugs. They improve the treatment of antineoplasic drugs as doxorubicin or paclitaxel, especially when matrices are nanoparticles. Polysorbate 80 (Tween 80) was widely used as an emulsifier with excellent effects in nanoparticles technology for biomedical applications. PLA-Tween 80 copolymers with various copolymer compositions were synthesized, nanoparticles were then prepared by dialysis method, paclitaxel loaded nanoparticles were characterized, in vitro drug release kinetics and drug encapsulation efficiency was studied [179] . Copolymers could encapsulate 4.7 % of the drug in the nanoparticles and release 62% of the encapsulated drug after 21 days. PLA-Tween 80 copolymer nanoparticles with higher Tween 80 content (15.3 %) in the copolymer were more advantageous for in vitro drug release than PLGA nanoparticles.
Copolymers poly( -caprolactone-co-DL-lactide) (Fig.17) can be mixed with one or more therapeutic agents. The preferred dosage forms for the copolymer are sustained release parenterals, bioerodible ointments, gels, creams, and similar soft dosage forms adapted for parenteral administration of therapeutic agents, other modes of administration (e.g., transdermal) and compositional forms (e.g., more rigid transdermal forms) [180] . Parenteral administration of a bioerodible composition of the copolymer can be effected by either subcutaneous, or intramuscular injection. Parenteral formulations of copolymer may be formulated by mixing one or more pharmaceuticals with the liquid copolymer. The bioerodible ointment, gel or cream can be injected as it is or in combination with one or more suitable auxiliary components. Parenteral delivery was preferred for administration of proteinaceous drugs such as growth factors, growth hormone. Poly(lactic-co-aspartic acid) (PLA-co-Asp) copolymers were synthesized by solution polycondensation procedure using manganese acetate and phosphoric acid as catalysts, different molar ratio PLA/L-aspartic acid (2.33/1, 1/1, 1/2.33) and N,N"-dimethylformamide/toluene as solvent mixtures [181] . Diclofenac sodium, a non steroidal anti-inflammatory drug was included in PLA-co-Asp copolymers. Drug delivery experiments were done in vitro by dialysis of copolymer/drug systems in phosphate buffer solution (pH=7.4, at 37 0 C), and by UV spectroscopy was determined the quantity of drug released at a given time and the cumulative drug released [182] . Diclofenac sodium content in the systems varied between 24 and 28 wt. %. At the end of dialysis time (356 h), diclofenac sodium release from the two systems was 62.47 wt. % and 36.09 wt. % respectively.
Native biodegradable polymers, such as starch, have been intensively studied in pharmaceutical applications (controlled drug delivery as they are biocompatible, present favourable release kinetics). However, native starch (being hydrophile) cannot be appropriate in some parenteral controlled drug delivery systems, as many drugs are released too quickly from human plasma: esterase cleaves the ester linkages in the systems, to release acetic acid and glycosidase further hydrolyzes the remaining polymer to glucose. Therefore, starch was modified with hydrophobic synthetic or natural polymers. It was grafted with L-lactic acid or poly(L-lactic acid) with low molecular weight ( Mn =3000), and some conjugated systems were obtained by physical or chemical conjugation with ampicillin sodium salt or acetylsalicylic acid [183, 184] . In vitro studies demonstrated the possible utilization of these copolymer matrices in drug delivery systems. The system that was obtained by chemical conjugation of ampicillin sodium salt with starch and lactic acid in the reaction medium, released 37 wt.% of the drug after 0.5 h, while the system prepared by chemical conjugation of ampicillin sodium with starch-co-lactic acid copolymer released 16 wt.%. The physically conjugated system released 50 wt. % after 0.75 h. Also, in the case of acetylsalicylic acid, the delivery in acid buffer solutions was 61.5 wt. % after 60 h for chemically conjugated system, comparative to physically conjugated one (48 wt. % of the drug after 83 h).
Recent pharmaceutical researches have specially focused on polymer micelles and nanoparticles assembled from block copolymers. A series of PLA-PEG diblock copolymers with a fixed PEG block and a varying PLA segment were assembled to form aqueous dispersions of spherical nanoparticles. The influence of PLA molecular weight on hydrodynamic size and micellar aggregation number of assemblies was determined. Their core-shell structure was ideally suited for targeted drug delivery (PEG is the hydrophilic shell and PLA is the hydrophobic core) [185] . Studies demonstrated that porous poly(L-lactide) membranes can be effective therapeutic systems in the treatment of periodontal disease. To develop a new periodontal therapeutic modality (guided tissue regeneration), biodegradable barrier membranes composed of porous PLLA films cast on poly(glycolide) were fabricated using an inair drying phase inversion technique. Flubiprofen and tetracycline, used in periodontal therapy for their tissue regenerating effects were incorporated in the membranes by adding the drugs in PLLA solutions. The drug release kinetics mainly depended on the hydrophilic-hydrophobic properties of drugs and the porosity of the membranes was dependent on the solvent composition of PLLA solution [186] . Nanoprecipitation method produced PLA nanospheres, combining ultra small size particles ( 100 nm), with high drug recovery; the nanospheres were loaded with a lipophilic tyrphostin compound (AG-1295), a potent antirestenotic agent. The nanospheres offer important advantages: reproducible carrier size in the nanometer range and the use of ingredients with low toxic potential, especially important in intravascular delivery. The method with appropriate modifications is suitable for producing vesicles and matrix type nanoparticles, nanocapsules and nanospheres. The antirestenotic formulation efficacy and in vivo drug disposition depended of the nanosphere size, and release kinetics of the carrier [187] .
Lactic acid polymers and copolymers in biomedical applications
PLA, PLLA, PDLLA and their copolymers are widely used in biomedical applications as: sutures for fixation of fractures, bone screws, vascular prostheses, surgical sutures, vascular grafts, intravascular stents, implants, artificial skin, nerve guides, meshes to facilitate dental extraction wound healing [16, [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] . Besides orthopedy, tissue engineering and regenerative medicine are also developed utilizing copolymer systems of lactic acid with monomers such as: glycolic acid (GA), ε-caprolactone (CL), δ-valerolactone (δ-VL), trimetylenecarbonate (TMC) and 1,5-dioxepane-2-one (DXO). Lactic acid copolymers with GA are more hydrophilic than PLLA, while ε-CL and TMC reduce the glass transition temperature. All these comonomers decrease the crystallinity of polylactides [199] [200] [201] . Last but not least, PLLA biodegradability could be improved, and melting temperature lowered by random copolymerization of LA or polylactides with the before mentioned comonomers, more flexible materials were obtained [202] [203] [204] [205] . PLGA copolymers found also widespread use for implantable devices in orthopaedic and dental applications, scaffolds for autografted new skin [16, [206] [207] [208] .
90/10 PGA/PLA (Vicryl) was the first clinical material, the absorbable suture was similar to that of PLA. Vicryl retained strength slightly longer and was absorbed sooner than glycolide, as the amorphous regions of PLGA were more susceptible to hydrolytic attack than crystalline ones [209] .
Low molecular weight PLGA is synthesized by thermal polycondensation of lactic acid and glycolic acid ( Mn 2000-3000), while high molecular weight PLGA samples Mn 500,000) are currently prepared by ring opening polymeriyation of glycolide and lactide in the presence of catalysts. As catalysts in copolymerization, to achieve copolymers for biomedical applications, mainly stannous (II) chloride and stannous (II) 2-ethylhexanoate were used. To control the reaction rate and average molecular weights, compounds with free hydroxyl groups were also utilized in catalyst systems: water, hydroxy acids, esters and various alcohols [10, 210] . Biocompatibility of lactic acid copolymers employed in manufacturing bone graft substitutes is affected by their chemical composition, molecular weight and cell environment, and by the methods of polymerization and processing. The in vitro bioactivity of 75:25 and 50:50 PLGA copolymers on human osteoblasts was investigated. The copolymers had no negative influence on cell morphology, viability and proliferation [211] .
To improve cell affinity of aliphatic polyesters, many efforts have been directed to modify their surface properties by adjusting the hydrophilic/hydrophobic balance [212, 213] . One of the possible and promising approaches to overcome this problem is to introduce hydrophilic functional groups in the aliphatic polyester. Rouhi and coworkers has [214] studied the self-assembled monolayer of PLA with final carboxyl functional groups and attached fibroblast cells to it, in the proteinaceous environment of culture medium. They found that the attached cells grow and spread substantially better on a carboxyl ended hydrophilic surface than on a methyl terminated hydrophobic one. Yao and co-workers [215, 216] synthesized oligomers of poly(Llactic-co-citric acid) (PLCA) (Fig. 18 ) from L(+)-lactic acid and citric acid, subsequently blends from PLLA and PLCA were achieved by solution casting with different PLLA/ PLCA ratios in order to improve PLLA hydrophilicity. Contact angle studies showed that blends hydrophilicity depends on PLCA to PLLA molar ratio. The degradation rate of blends had a higher value than that of unblended PLLA. A major problem in the use of PLLA in some biomedical application is its very low degradation rate, hydrophobicity and lack of reactive groups. Blending PLLA with PLCA could therefore be a convenient way to improve its hydrophilicity and degradation behaviour. The carboxyl groups of PLCA could be used to immobilize bioactive molecules on the surface of PLLA based devices.
A scaffold is required as a physical support, guiding the formation of a new organ, as well as an adhesive substrate for cells implanted for its generation. Scaffolds should be biocompatible and biodegradable. The three-dimensional structure should be highly porous and the pores should be interconnected. The surface to volume ratio of the pores must be large. Scaffolds should also provide the necessary initial support for the attachment and proliferation of cells, and for retention of their differentiated functions [217] Poly( -hydroxyacids) generate acid degradation products at the implanted site which evoke undesirable tissue reaction [218, 219] . The acid byproduct may lead to local disturbance, due to poor vascularization in the surrounding tissue. Chitosan may be combined with acid producing biodegradable polymers, so that local toxicity due to acid byproducts can be alleviated. A novel cytocompatible graft copolymer of chitosan and L(+)-lactic acid was prepared by grafting L(+)-lactic acid on the amino groups of chitosan without a catalyst [220] . The structure of the graft copolymer is presented in Figure 19 . The amino groups of chitosan were protonated and chitosan amino lactate salt was formed, as chitosan was dissolved in L(+)-lactic acid aqueous solution. The dehydration of the salt occured to form amide groups between chitosan and L(+)-lactic acid by heating the solution, the polycondensation of L(+)-lactic acid was achieved at the same time. Fibroblast culture was performed to evaluate cell proliferation on copolymers films. The results showed obviously that the cell growth rate on the copolymers films was faster than on chitosan.
The host tissue response to PLGA and small intestinal submucosa (SIS) -based scaffolds subcutaneously implanted in Fischer rats was tested. The results revealed that PLGA based scaffolds resulted in severe post-implantation inflammation, whereas SIS-based scaffolds induced only a slight postimplantation inflammation and PLGA/SIS based copolymer yielded intermediate results [221] . PLLA and PDLLA utilized for surgical implants or pharmaceutical applications indicated no inflammatory reaction, demonstrating their tissue compatibility. In 1966 PLLA was firstly applied as plates and screws for fixation of fractured bones. The replacement of medical devices by resorbable PLLA means that a second operation is no longer necessary. These resorbable polyesters can be utilized for the manufacture of clips, nets and other devices for wound closure. When PLLA is used in orthopaedic and oral surgery as fixation or augmentation devices, PLLA of high molecular weight is neeeded to produce devices of high mechanical strength. In recent years, the experimental and clinical utilization of PLLA in the field of orthopaedics has seen tremendous growth, especially as fracture fixation devices and scaffolds for tissue ingrowth, due to its high tensile strength and low elongation at break [6, 222] . However, PLLA present insufficient stiffness as bone plates for long bones, producing difficulties in the fixation of high strength materials such as femur. An ideal bone composite material is biocompatible, biodegradable, capable to initiate osteogenesis, has mechanical properties and composition similar to that of bone. A large number of materials like biopolymers, ceramics, metals (of which only biopolymers and ceramics have mechanical properties similar to bone) are known to be biocompatible. Biodegradability together with biocompatibility and suitable mechanical properties are found only in a small group of materials (biopolymers as gelatin, collagen), synthetic polymers poly(lactides-co-glycolides), polylactides, polyanhydrides. Samples of high-molecular weight PLLA ( Mv =9 10 5 ) were synthesized for plates and screws used in internal fixation of jaw fractures and were implanted subcutaneously in the backs of rats to study tissue reaction to PLLA and to follow the degradation process. Except for the early and final parts of the implant period, no acute or chronic inflammatory reaction was observed, no implant was rejected. For bone healing, the long degradation time of PLLA is not an impediment since it does not provide corrosion problem, it is absorbable to ensure progressive transfer of stresses to healing bone and provides safe reduction of fracture [223] .
Bone morphogenetic proteins (BMP) induce bone formation in vivo and clinical application in repair of bone fractures and defects is expected. However, appropriate systems to deliver BMP for clinical use need to be developed. A new synthetic biodegradable block copolymer poly(D,L-lactic acid-co-dioxanone -co-polyethylene) (PDLLA-DX-PEG) was synthesized to serve as a biocompatible, biodegradable polymer for recombinant human rhBMP-2 delivery systems, Fig. 20 [224] . Animal experiments demonstrated that new bone was efficiently formed and a large bone defect was repaired using PLA-DX-PEG/rhBMP-2 composites. This new synthetic block copolymer can be used for rhBMP-2 delivery, in various clinical situations involving repair of bone and leading to great changes in orthopaedic treatment. Biodegradable polylactide implants allow secure fixation of osteochondral fractures with minimal adverse effects. Composite implants obtained from poly (L(+)/DLlactides) (70/30) and 10 % tricalcium phosphate were tested for their osteoconductive effect and whether degradation could be positively influenced and adverse effects minimized using such implants [225] . All fractures healed completely without displacement or clinically relevant complications. After 36 months, the pins had microscopically disappeared and the canals were filled with bone tissue.
The adsorption, biocompatibility and fixation properties of self -reinforced SR-PLLA (PLLA matrix reinforced with PLLA fibers) and SR-PDLA (PDLLA matrix reinforced with PLLA fibers) were investigated in cancellous bone of rats. Roentgenographic, microradiographic, histologic, histomorphometric studies were done. Histologically, no evidence of inflammation or foreign-body reaction in tissues was observed. Implants made of SR-PLLA in rats proved to be biocompatible and slowly absorbable and they possessed sufficient mechanical properties for fixation of osteotomies [226] .
A novel amorphous calcium phosphate/PLLA composite was tested as cartillage in tissue engineering [227] . The treatment of PLLA incorporated with a basic fibroblast growth factor, to repair cartillage defects in rabbits, improved defect filling compared with that left untreated; the regenerated tissue was mainly fibrocartilage and showed little bone formation with only a small amount of collagen type II. When implanted with calcium phosphate/PLLA and basic fibroblast growth factor, most of the defects were filled with a well established layer of cartilage tissue and abundance of cartilaginous extra-cellular matrix accumulation was observed.
Bioresorbable devices made of composites of hidroxyapatite/PLLA presented the highest mechanical properties (bending strength of about 270 MPa, impact strength 166 kJ/m 2 , two times more raised than of polycarbonate) and could be therefore utilized in orthopaedics, maxillofacial, craniofacial, plastic and reconstructive surgery [228] . Beta-calcium phosphates (b-TCP) PLLA composites are also extensively utilized in tissue engineering for regeneration of bone tissues because of their biocompatibility, biodegradation and good mechanical properties. The degradation rate of these scaffolds could be adjusted by the additional fraction of b-TCP to meet the requirements of in vivo application [229] . A new method to prepare poly(Llactide)/calcium metaphosphate (PLA/CMP) composite scaffolds was also investigated for effective bone tissue engineering. The scaffolds were seeded by osteoblasts and cultured in vitro or implanted subcutaneously into mice for up to 5 weeks. They had a homogeneously interconnected porous structure, without a skin layer and they exhibited a narrower pore size distribution and higher mechanical strength in comparison with scaffolds made by a solvent casting method [230] .
Hydroxyapatite (Hap)-biodegradable polymer composites were prepared by in situ hydrolysis of α-Ca 3 (PO 4 ) 2 in the presence of PLA or PLGA at 37 0 C and 16 h [231] .
The polymer acted as a continuous phase, in which the mineral was dispersed. Such composites combine reasonable mechanical strength with the ability to induce bone growth (osteoconductivity) and the ability to be replaced by the native bone tissue (resorbability). Tissue engineering is also an alternative route to regenerate articular defects. A blend of starch and PLLA was used in the cartillage side with adequate hydration capacity. The bioactivity tests demonstrated that the bone layer could induce the formation of calcium phosphate layer in vitro, whereas the cartillage layer did not exhibit the ability for calcification [232] .
Other studies explored the possibility of growing lung cells on PDLLA scaffolds to in future engineer pulmonary tissue for human implantation. PDLLA was investigated in two forms, as planar discs and as 3D foams and it was demonstrated that PDLLA was not only non-toxic to pneumocytes but also actively supported their growth [233] . Bone growth factors are small proteins contained by bone tissue. The most intensively investigated bone growth factors are the bone morphogenetic proteins (BMPs). Their local application induces bone formation in experimental fractures and bone defects. Several biodegradable materials have been investigated as carriers for bone growth factors including organic materials, ceramics, PLA and PLGA copolymer. PLA and PLGA are the most frequently used components of bioabsorbable carriers for bone growth factors in experimental studies [233] [234] [235] [236] .
Bone defects may be caused by severe trauma and if it is an open fracture, infection is highly suspected. Systemic antibiotic therapy has the disadvantages of need for long-term treatment due to being unable to create a high local concentration of drug and might cause the development of drug resistant bacterial strains. Impaired vascularity of infected bone necessitates the use of higher drug doses, being another disadvantage. The disadvantages of additional surgery (local antibiotic drug delivery systems) are eliminated if biodegradable systems lactic acid polymers, collagen, gelatine are used as carriers of drugs. Antibiotic delivery may prevent osteomyellitis following surgery. Biodegradable implants containing gentamicin and PDLLA were prepared by compressing a polymer-drug mixture. The release rate was controlled by drug diffusion and polymer degradation and after hydrolysis the remaining products were metabolized in the citric acid cycle. Local application of antibiotic coated orthopedic devices containing PDLLA and 10 % gentamicin significantly reduced implant related infection in rats [237] .
Clinical use of resorbable membranes concerns their resorption time and the effects of their degradation on bone formation. In recent years, several types of resorbable membranes were proposed for guided tissue regeneration (GTR) or guided bone regeneration (GBR).The evaluation of early tissue reactions to the insertion of polylactic membranes was studied in tibia rabbit. Histological analyses demonstrated that no detrimental effects in bone tissue around the membrane were observed and the membrane appeared to have mechanical stability for the time necessary for bone regeneration [238] . Researchers tried to monitor tissue reactions toward subcutaneously implanted biodegradable PLA hollow fibres. The tissue reactions in the immediate surrounding of the implants were monitored by studying the activity pattern of seven enzymes as a function of time. It was concluded that PLA hollow fibres used in the implantation studies were completely tissue compatible and had a very low inflammatory potential [5] .
Biodegradable films from L,L-lactide, D,L-lactide and -caprolactone copolymers were achieved and tested for the prevention of postoperative pleural and pericardial adhesion. At 1 week, 1 month and 2 months no adhesion was observed between lung and thorax wall where the parietal pleura had been excised, the flexibility and mechanical properties were adequate [239] . Polysaccharides grafted with lactic or polylactic acid present nowadays an attractive research field, as they are biodegradable, do not generate acid degradation products to provoke undesirable tissue reactions, are consequently utilized in several biomedical applications [240, 241] .
One of the main limitations of using PLA for tissue engineering scaffolds is polymer hydrophobicity and low biocompatibility. Also, porous scaffolds fabricated with PLA/PLGA have lower density than that of water, prior to wetting. Due to high porosity they float with cell culture medium prior to extensive wetting periods. Additionally, this poor wetting results in poor distribution of cells during seeding. A number of approaches have been developed to improve hydrophilicity of these polymer scaffolds and thus to ensure uniform and dense cell seeding. One of these approaches involves use of copolymers of polylactic acid and polyethylene oxide or polyethylene glycol. Copolymerizing hydrophobic PLA with hydrophilic PEG to achieve PLA-PEG-PLA triblock copolymers (Fig. 21) is an effective way to enhance the biocompatibility of hydrophobic PLA [242] . Fig. 21 . Structure of PLA-PEG-PLA tribloc copolymer.
Also poly(lactic acid)-co-poly(ethylene glycol) (PLA-PEG) diblock copolymer was tested in biomedical applications. By altering PEG content of diblock copolymers it is possible to control the adsorption of adhesion proteins and since cell adhesion takes place only in the presence of serum proteins, controlling adhesion of serum proteins means controlling cell adhesion and cell shape. The effect of marrow stromal cell differentiation to the osteoblastic phenotype was evaluated on PLA-PEG scaffolds compared to PLA. PLA-PEG scaffolds showed strong improvement as measured by 2-fold increase in alkaline phosphatase activity and mineralization [243] .
The development of biomimetic materials and their processing into three-dimensional cell carrying scaffolds is one promising tissue engineering strategy to improve cell adhesion, growth and differentiation on polymeric constructs developing mature and viable tissues. Another study was concerned with the fabrication of scaffolds made from amine-reactive diblock copolymers of N-succinimidyltartrate monoamine PEGb-PDLLA, which are able to suppress unspecific protein adsorption and to covalently bind proteins or peptides (Fig. 22 ) [244] . A technique was developed involving lipid microparticles, which served as biocompatible porogens on which the scaffold forming polymer was precipitated in the porogen extraction media (n-hexane). Porogen melting during extraction and polymer precipitation step led to an interconnected network of pores. Poly(L-lactic acid)-co-poly(L-lactic-co-citric acid)-co-poly(ethylene glycol) multiblock copolymers (PLLA-PLCA-PEG) were synthesized by direct polycondensation reaction of poly(lactic-co-citric acid) (PLCA) copolymer with PEG and were subsequently used to modify PLLA through blending, to adjust the hydrophilicity and hydrolytic degradation rates of PLLA scaffolds. Compressive testing research showed that the mechanical flexibility improved as the content of PLLA-PLCA-PEG copolymers in the scaffolds increased. Tetrandrine (TED) (bis-benzylisoquinoline alkaloid isolated from the dried root of the natural Chinese herb Stephania tetrandra) encapsulation efficiency was enhanced when the amount of PLLA-PLCA-PEG increased, because of acid -base interaction between carboxyl acid groups of the copolymer with TED [191] . TED has been used as an effective antiinflammatory and antitumor compound and many studies support the claim that TED has potential pharmacological application in cancer therapy [245, 246] . PLLA scaffold modification with PLLA-PLCA-PEG will broaden its applications in tissue engineering.
New graft copolymers (hyaluronic acid-co-PLA) (HA-co-PLA) were synthesized as a new class of biomaterials able to produce hydrophobically associated hydrogels, suitable for tissue engineering or drug delivery applications. As a scaffold constituent, HA lacks mechanical properties, has low resistance to stress and degradation. Chemical derivatives of HA presented better mechanical properties and hydrolytical resistance [247] .
Hyaluronic acid was immobilized onto the surface of macroporous biodegradable (PLGA) scaffolds to enhance the attachment, proliferation, and differentiation of chondrocytes for cartillage tissue engineering [248] . The PLGA scaffolds were prepared by blending PLGA with varying amounts of amine-terminated PLGA-PEG diblock copolymer. They were fabricated by a gas foaming/salt leaching method. HA was chemically conjugated to the surface exposed amine groups on the prefabricated scaffolds. The amount of surface exposed free amine groups was quantitatively determined by conjugating an amine-reactive fluorescent dye to the PLGA blend films. When chondrocytes were seeded within HA modified PLGA scaffolds, enhanced cellular attachment was observed compared to unmodified PLGA scaffolds. Histological examination of the resultant cartilage tissue revealed that HA modified scaffolds excelled in inducing cartilage tissue formation in terms of collagen type expression and tissue morphological characteristics.
Biodegradable stents should deliver a temporary longitudinal and radial straightening effect, offer better physiological repair, allow reconstitution of local vascular compliance and should not restrict surgical or interventional revascularization, thus allowing the possibility of growth and late positive remodeling. The ideal characteristics of a biodegradable stent have been defined as: (1) sufficient radial strength to prevent vascular recoil, (2) minimal thrombotic and inflammatory response, (3) avoidance of intimal proliferation, (4) reabsorption of stent components within months, (5) no release of toxic products or embolic material during breakdown and (6) easy processing and sterilization [249] . Poly(L-lactic acid) is the most commonly used of all biodegradable polymers. The bioresorbable vascular scaffold stent (BVS) (Abbott Laboratories, Abbott Park, IL, USA) is made from poly-L-lactic acid and results from clinical trials are recently published [250] [251] [252] . While the study demonstrated feasibility, it was a very small patient population (30 patients) and the degradation rate was slow (more than 1 year), which some consider to be one of the drawbacks of polymeric biodegradable stents. One of the earliest devices in this field was the Igaki-Tamai coronary stent (Kyoto Medical Planning Co., Kyoto, Japan), which is also manufactured from PLLA with a zigzag helical coil design [252] . A small trial (15 patients) with 6 months follow-up showed no pronounced intimal hyperplasia, unlike in stainless steel stents. There was evidence of vascular remodeling at the stented site, with an increase of the stent cross-sectional area associated with a decrease in the lumen cross-sectional area, although after the third month no further stent expansion was observed [253] . Although these promising findings demonstrated feasibility and safety, with acceptable efficacy in human coronary arteries, polymeric biodegradable stents have not yet been used in the pediatric population.
Conclusions
In biomedical applications, there is an increasing interest in poly( -hydroxy acids), especially PLLA, PDLLA, PGA, PLGA, as devices made from these resorbable polymers can overcome problems associated with metal implants: stress protection, corrosion problems, the necessity of implant removal, refracture. In addition, lactic acid copolymers, especially with glycolic acid are very suitable in controlled drug release systems as besides biodegradability, biocompatibility, non-toxicity, they include enough active substance and keep it unaltered to the action site, they release the drug with a convenient rate at the target site, do not require surgical removal after the drug has been depleted.
Lactic acid polymers synthesis and physical properties presented in the review and some recent research studies on polycondensation procedure (solid state polymerization, azeotropic condensation polymerization) prove that they can be manufactured for a wide range of applications.
